Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 18632621)

1.

Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer.

Basu A, Contreras AG, Datta D, Flynn E, Zeng L, Cohen HT, Briscoe DM, Pal S.

Cancer Res. 2008 Jul 15;68(14):5689-98. doi: 10.1158/0008-5472.CAN-07-6603.

2.

Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40.

Basu A, Banerjee P, Contreras AG, Flynn E, Pal S.

PLoS One. 2011;6(8):e23919. doi: 10.1371/journal.pone.0023919. Epub 2011 Aug 23.

4.

Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development.

Basu A, Datta D, Zurakowski D, Pal S.

J Biol Chem. 2010 Aug 13;285(33):25196-202. doi: 10.1074/jbc.M110.119446. Epub 2010 Jun 16.

5.

Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.

Zhao X, Zhu DM, Gan WJ, Li Z, Zhang JL, Zhao H, Zhou J, Li DC.

Oncol Rep. 2013 Mar;29(3):1019-26. doi: 10.3892/or.2012.2203. Epub 2012 Dec 19.

PMID:
23254994
6.

Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis.

Yoshiji H, Kuriyama S, Ways DK, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Tsujinoue H, Nakatani T, Shibuya M, Fukui H.

Cancer Res. 1999 Sep 1;59(17):4413-8.

7.

Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells.

Shih SC, Mullen A, Abrams K, Mukhopadhyay D, Claffey KP.

J Biol Chem. 1999 May 28;274(22):15407-14.

9.

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.

Cancer Res. 2003 Jun 15;63(12):3403-12.

10.

The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP.

Mol Cell Biol. 1997 Sep;17(9):5629-39.

13.

Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.

Abdelrahim M, Baker CH, Abbruzzese JL, Safe S.

J Natl Cancer Inst. 2006 Jun 21;98(12):855-68.

14.
15.

Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells.

Neid M, Datta K, Stephan S, Khanna I, Pal S, Shaw L, White M, Mukhopadhyay D.

J Biol Chem. 2004 Feb 6;279(6):3941-8. Epub 2003 Nov 6.

18.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

19.

KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.

Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H.

Hepatology. 1999 Nov;30(5):1179-86.

PMID:
10534339
20.

Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.

Xu H, Czerwinski P, Hortmann M, Sohn HY, Förstermann U, Li H.

Cardiovasc Res. 2008 May 1;78(2):349-55. Epub 2007 Dec 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk